Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

203 Press Releases
DateTitleCompany
20 Jan 16 One-hour diagnosis of heart attack possible with troponin T test from Roche Roche,
Published by
PharmiWeb.com
22 Dec 15 New Roche HBV Test expands cobas® 4800 System menu Roche,
Published by
PR Newswire
21 Dec 15 Roche receives FDA approval for HIV-1 viral load test on the cobas® 6800/8800 Systems Roche,
Published by
PR Newswire
18 Dec 15 FDA grants Roche’s Alecensa (alectinib) accelerated approval for people with a specific type of lung cancer Roche,
Published by
PharmiWeb.com
23 Sep 15 New data will be presented for Roche’s Esbriet in idiopathic pulmonary fibrosis at European Respiratory Society Congress 2015 Roche,
Published by
Pharmiweb.com
11 Sep 15 For the 7th year running, Roche ranked most sustainable healthcare company in the Dow Jones Sustainability Indices Roche,
Published by
PharmiWeb.com
31 Jul 15 Roche's Perjeta regimen approved in Europe for use before surgery in early stage aggressive breast cancer Roche,
Published by
PharmiWeb.com
16 Jul 15 Reminder: Invitation to Roche’s Half Year Results 2015 Roche,
Published by
PharmiWeb.com
16 Jul 15 Reminder: Roche Analyst Event on Diagnostics Division at AACC 2015 Roche,
Published by
PharmiWeb.com
16 Jul 15 Invitation to Roche’s Half Year Results 2015 Roche,
Published by
PharmiWeb.com
13 Jul 15 In a pivotal study, Roche’s investigational immunotherapy atezolizumab shrank tumours in people with a specific type of bladder cancer Roche,
Published by
PharmiWeb.com
30 Jun 15 Roche’s ocrelizumab significantly reduced both relapses and disability progression versus interferon beta-1a (Rebif®) in two Phase III studies in multiple sclerosis Roche,
Published by
PharmiWeb.com
26 Jun 15 Roche’s Perjeta recommended for approval in EU for use before surgery in HER2-positive early breast cancer Roche,
Published by
PharmiWeb.com
22 Jun 15 Roche unveils powerful innovations in diagnostics at EuroMedLab Roche,
Published by
PharmiWeb.com
18 Jun 15 Roche to provide HIV diagnostic solutions to Global Fund Roche,
Published by
PR Newswire
16 Jun 15 Roche employees unite to raise funds for children in need Roche,
Published by
PharmiWeb.com
10 Jun 15 Roche receives U.S. FDA breakthrough therapy designation for ACTEMRA/RoACTEMRA in systemic sclerosis, and will present new study results at EULAR 2015 Roche,
Published by
PharmiWeb.com
09 Jun 15 Roche To Develop Companion Diagnostic Test For Acute Coronary Syndrome Roche,
Published by
PR Newswire
01 Jun 15 Roche’s Perjeta regimen helped people with HER2-positive early breast cancer live longer without their disease returning or getting worse compared to Herceptin and chemotherapy Roche,
Published by
PharmiWeb.com
04 Jun 15 Roche receives FDA clearance for the cobas® HSV 1 and 2 Test for the detection of herpes simplex virus Roche,
Published by
PR Newswire
30 Sep 13 Data show Roche's new subcutaneous form of Herceptin is preferred by patients and could save resources in Europe's hospitals Roche
05 Nov 14 Roche to invest 450 million Swiss Francs in new diagnostic manufacturing facility in China Roche,
Published by
PharmiWeb.com
17 Nov 14 Frontline staff believe patient care is suffering as a result of cancer capacity challenges in the NHS, new national survey reveals1 Roche,
Published by
PharmiWeb.com
26 May 15 Roche receives FDA clearance for the cobas® Cdiff Test to detect Clostridium difficile Roche,
Published by
PR Newswire
11 May 15 Roche Receives FDA Approval for cobas® KRAS Mutation Test Roche,
Published by
PR Newswire
19 Aug 13 Patients suffering from potentially fatal forms of vasculitis could benefit from first ever licensed treatment Roche,
Published by
Reynolds-MacKenzie
05 Mar 15 Roche Products Ltd?has been recognised as one of Britain’s Top Employers 2015 Roche,
Published by
PharmiWeb.com
24 Jan 14 NICE gives green light to first licensed treatment for patients suffering from potentially fatal forms of vasculitis Roche
09 Dec 13 GA101 (obinutuzumab) becomes first and only treatment to demonstrate superior efficacy over MabThera® (rituximab) in a first-line Phase III CLL study Roche
23 May 14 China anti-graft watchdog visits Roche amid pharma crackdown Roche,
Published by
Reuters
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.